Healthcare provider profile · identity verified

Andre John Leonard, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · WILMINGTON, NC · NPI 1720019193

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Andre John Leonard, M.D. received $46.93 in general payments during 2025 across 3 reported records.

Hologic Sales and Service, LLC accounted for 40.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$46.93

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Hologic Sales and Service, LLC	Unresolved — no canonical attribution shown	$18.97	40.4%	1	2025
Phathom Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$14.45	30.8%	1	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$13.51	28.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$46.93	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
APTIMA Normalized: aptima	Device	Hologic Sales and Service, LLC	$18.97	1	2025
Source payment records 2025-10-01 · Hologic Sales and Service, LLC · $18.97 · Open Payments source
THINPREP 2000 PROCESSOR Normalized: thinprep 2000 processor	Device	Hologic Sales and Service, LLC	$18.97	1	2025
Source payment records 2025-10-01 · Hologic Sales and Service, LLC · $18.97 · Open Payments source
VOQUEZNA Normalized: voquezna	Drug	Phathom Pharmaceuticals, Inc.	$14.45	1	2025
Source payment records 2025-06-03 · Phathom Pharmaceuticals, Inc. · $14.45 · Open Payments source
OTEZLA Normalized: otezla	Drug	Amgen Inc.	$13.51	1	2025
Source payment records 2025-08-19 · Amgen Inc. · $13.51 · Open Payments source
REPATHA Normalized: repatha	Biological	Amgen Inc.	$13.51	1	2025
Source payment records 2025-08-19 · Amgen Inc. · $13.51 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	798	216
Levothyroxine Sodium	Levothyroxine Sodium	756	199
Atorvastatin Calcium	Atorvastatin Calcium	707	188
Rosuvastatin Calcium	Rosuvastatin Calcium	702	192
Losartan Potassium	Losartan Potassium	534	143
Metoprolol Succinate	Metoprolol Succinate	471	124
Alprazolam	Alprazolam	390	83
Omeprazole	Omeprazole	390	107
Hydrochlorothiazide	Hydrochlorothiazide	352	104
Gabapentin	Gabapentin	346	89
Lisinopril	Lisinopril	265	72
Pantoprazole Sodium	Pantoprazole Sodium	261	76
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	223	43
Furosemide	Furosemide	220	70
Fluoxetine Hcl	Fluoxetine Hcl	218	51
Duloxetine Hcl	Duloxetine Hcl	208	42
Tramadol Hcl	Tramadol Hcl	205	45
Sertraline Hcl	Sertraline Hcl	198	51
Zolpidem Tartrate	Zolpidem Tartrate	187	50
Lorazepam	Lorazepam	178	34
Metformin Hcl	Metformin Hcl	174	47
Ozempic	Semaglutide	174	33
Simvastatin	Simvastatin	174	44
Temazepam	Temazepam	165	32
Venlafaxine Hcl Er	Venlafaxine Hcl	152	32
Allopurinol	Allopurinol	149	35
Mirtazapine	Mirtazapine	143	42
Escitalopram Oxalate	Escitalopram Oxalate	141	33
Synthroid	Levothyroxine Sodium	138	33
Clonazepam	Clonazepam	134	25
Tamsulosin Hcl	Tamsulosin Hcl	134	44
Trazodone Hcl	Trazodone Hcl	133	30
Bupropion Xl	Bupropion Hcl	132	35
Albuterol Sulfate Hfa	Albuterol Sulfate	128	40
Meloxicam	Meloxicam	128	42
Metformin Hcl Er	Metformin Hcl	126	37
Esomeprazole Magnesium	Esomeprazole Magnesium	124	26
Potassium Chloride	Potassium Chloride	123	35
Oxycodone Hcl	Oxycodone Hcl	116	24
Ezetimibe	Ezetimibe	110	35
Olmesartan Medoxomil	Olmesartan Medoxomil	110	37
Pravastatin Sodium	Pravastatin Sodium	104	29
Repatha Sureclick	Evolocumab	104	16
Celecoxib	Celecoxib	101	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	99	12
Prednisone	Prednisone	96	47
Telmisartan	Telmisartan	93	24
Eliquis	Apixaban	92	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	92	23
Mounjaro	Tirzepatide	92	21
Atenolol	Atenolol	87	27
Clopidogrel	Clopidogrel Bisulfate	86	24
Xarelto	Rivaroxaban	86	15
Metoprolol Tartrate	Metoprolol Tartrate	85	21
Donepezil Hcl	Donepezil Hcl	81	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	22
Valacyclovir	Valacyclovir Hcl	78	39
Carvedilol	Carvedilol	77	19
Aripiprazole	Aripiprazole	76	11
Citalopram Hbr	Citalopram Hydrobromide	74	17
Spironolactone	Spironolactone	74	23
Fluticasone Propionate	Fluticasone Propionate	73	23
Quetiapine Fumarate	Quetiapine Fumarate	73	11
Jardiance	Empagliflozin	71	18
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	69	11
Pregabalin	Pregabalin	66	19
Glimepiride	Glimepiride	64	17
Methocarbamol	Methocarbamol	63	15
Farxiga	Dapagliflozin Propanediol	60	17
Montelukast Sodium	Montelukast Sodium	60	20
Clonidine Hcl	Clonidine Hcl	55	20
Hydralazine Hcl	Hydralazine Hcl	53	11
Memantine Hcl	Memantine Hcl	52	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	52	51
Ondansetron Hcl	Ondansetron Hcl	50	17
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	49	11
Promethazine Hcl	Promethazine Hcl	49	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	15
Estradiol	Estradiol	45	19
Ibandronate Sodium	Ibandronate Sodium	45	12
Trulicity	Dulaglutide	45	suppressed
Finasteride	Finasteride	44	15
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	43	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	43	11
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Ibuprofen	Ibuprofen	41	13
Warfarin Sodium	Warfarin Sodium	41	suppressed
Nystatin	Nystatin	40	23
Tizanidine Hcl	Tizanidine Hcl	40	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Methylprednisolone	Methylprednisolone	37	35
Myrbetriq	Mirabegron	37	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	36	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Ondansetron Odt	Ondansetron	31	14
Testosterone Cypionate	Testosterone Cypionate	31	suppressed
Azithromycin	Azithromycin	30	30
Famotidine	Famotidine	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	20
Diazepam	Diazepam	29	suppressed
Eszopiclone	Eszopiclone	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	23
Meclizine Hcl	Meclizine Hcl	28	suppressed
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Valsartan	Valsartan	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Repatha Syringe	Evolocumab	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	24
Synjardy Xr	Empagliflozin/Metformin Hcl	26	suppressed
Acyclovir	Acyclovir	25	suppressed
Ambien	Zolpidem Tartrate	25	suppressed
Armour Thyroid	Thyroid,pork	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Cephalexin	Cephalexin	24	16
Fluconazole	Fluconazole	23	15
Baclofen	Baclofen	22	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Colchicine	Colchicine	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Prazosin Hcl	Prazosin Hcl	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	16
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	18	suppressed
Glipizide	Glipizide	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Belsomra	Suvorexant	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	15
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Cefuroxime	Cefuroxime Axetil	14	14
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Wegovy	Semaglutide	14	suppressed
Zoloft	Sertraline Hcl	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Nurtec Odt	Rimegepant Sulfate	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Testosterone	Testosterone	13	suppressed
Torsemide	Torsemide	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	12	suppressed
Haegarda	C1 Esterase Inhibitor	12	suppressed
Lactulose	Lactulose	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Zyprexa	Olanzapine	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Linzess	Linaclotide	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Ramipril	Ramipril	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$46.93 · 3 records	Hologic Sales and Service, LLC	APTIMA, OTEZLA, REPATHA, THINPREP 2000 PROCESSOR, VOQUEZNA	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error